323
Views
13
CrossRef citations to date
0
Altmetric
Articles

Intratympanic steroids as a salvage therapy for severe to profound idiopathic sudden sensorineural hearing loss

, , , , , , & show all
Pages 966-971 | Received 08 May 2018, Accepted 01 Jul 2018, Published online: 31 Oct 2018

References

  • Alexander TH, Harris JP. Incidence of sudden sensorineural hearing loss. Otol Neurotol. 2013;34:1586–1589.
  • Filipo R, Attanasio G, Russo FY, et al. Intratympanic steroid therapy in moderate sudden hearing loss: a randomized, triple-blind, placebo-controlled trial. Laryngoscope. 2013;123:774–778.
  • Filipo R, Attanasio G, Viccaro M, et al. Hyperbaric oxygen therapy with short duration intratympanic steroid therapy for sudden hearing loss. Acta Otolaryngol. 2012;132:475–481.
  • Attanasio G, Covelli E, Cagnoni L, et al. Does the addition of a second daily session of hyperbaric oxygen therapy to intratympanic steroid influence the outcomes of sudden hearing loss? Acta Otorhinolaryngol Ital. 2015;35:272–276.
  • Wilson WR, Byl FM, Laird N. The efficacy of steroids in the treatment of idiopathic sudden hearing loss. A double-blind clinical study. Arch Otolaryngol. 1980;106:772–776.
  • Seggas I, Koltsidopoulos P, Bibas A, et al. Intratympanic steroid therapy for sudden hearing loss: a review of the literature. Otol Neurotol. 2011;32:29–35.
  • Rohrmeier C, Koemm N, Babilas P, et al. Sudden sensorineural hearing loss: systemic steroid therapy and the risk of glucocorticoid-induced hyperglycemia. Eur Arch Otorhinolaryngol. 2013;270:1255–1261.
  • Salt AN, Plontke SK. Local inner-ear drug delivery and pharmacokinetics. Drug Discov Today. 2005;10:1299–1306.
  • Battaglia A, Burchette R, Cueva R. Combination therapy (intratympanic dexamethasone + high-dose prednisone taper) for the treatment of idiopathic sudden sensorineural hearing loss. Otol Neurotol. 2008;29:453–460.
  • Swan EE, Mescher MJ, Sewell WF, et al. Inner ear drug delivery for auditory applications. Adv Drug Deliv Rev. 2008;60:1583–1599.
  • Van Wijck F, Staecker H, Lefebvre PP. Topical steroid therapy using the Silverstein MicroWick in sudden sensorineural hearing loss after failure of conventional treatment. Acta Otolaryngol. 2007;127:1012–1017.
  • Kakehata S, Sasaki A, Futai K, et al. Daily short-term intratympanic dexamethasone treatment alone as an initial or salvage treatment for idiopathic sudden sensorineural hearing loss. Audiol Neurootol. 2011;16:191–197.
  • Park SH, Moon IS. Round window membrane vibration may increase the effect of intratympanic dexamethasone injection. Laryngoscope. 2014;124:1444–1451.
  • Lefebvre PP, Staecker H. Steroid perfusion of the inner ear for sudden sensorineural hearing loss after failure of conventional therapy: a pilot study. Acta Otolaryngol. 2002;122:698–702.
  • Haynes DS, O′Malley M, Cohen S, et al. Intratympanic dexamethasone for sudden sensorineural hearing loss after failure of systemic therapy. Laryngoscope. 2007;117:3–15.
  • Gundogan O, Pinar E, Imre A, et al. Therapeutic efficacy of the combination of intratympanic methylprednisolone and oral steroid for idiopathic sudden deafness. Otolaryngol Head Neck Surg. 2013;149:753–758.
  • Filipo R, Covelli E, Balsamo G, et al. Intratympanic prednisolone therapy for sudden sensorineural hearing loss: a new protocol. Acta Otolaryngol. 2010;130:1209–1213.
  • Rauch SD, Halpin CF, Antonelli PJ, et al. Oral vs intratympanic corticosteroid therapy for idiopathic sudden sensorineural hearing loss: a randomized trial. Jama. 2011;305:2071–2079.
  • Filipo R, Attanasio G, Russo FY, et al. Oral versus short-term intratympanic prednisolone therapy for idiopathic sudden hearing loss. Audiol Neurotol. 2014;19:225–233.
  • Plontke SK, Löwenheim H, Mertens J, et al. Randomized, double blind, placebo controlled trial on the safety and efficacy of continuous intratympanic dexamethasone delivered via a round window catheter for severe to profound sudden idiopathic sensorineural hearing loss after failure of systemic therapy. Laryngoscope. 2009;119:359–369.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.